Mouse experiments on URO and RIF will commence in January 2025
December 9, 2024 – Pump Science released the latest roadmap update, outlining key milestones for the coming year. Here are some key developments:
December 24, 2024:
Pump Science will announce new strategic partnerships and prepare for upcoming mouse experiments, while establishing relevant agreements. This lays the foundation for the company's research in 2025.January 25, 2025:
The company will launch mouse experiments targeting URO (Urolithin A)andRIF (Rifampicin). These experiments aim to investigate the potential health benefits of these two compounds, particularly their applications in slowing aging and promoting cellular health.February 25, 2025:
Pump Science will collaborate withVitaDAOto initiate the research and development of a new compound. This collaboration will accelerate research in the fields of anti-aging and other health areas, and advance progress in decentralized science (DeSci).March 25, 2025:
The company will launcha supplement reservation and marketplace platform, enabling consumers to conveniently purchase cutting-edge health products based on scientific research.April 25, 2025:
Pump Science will initiatedecentralized human trials, paving the way for a more open and inclusive model of clinical trials. At the same time, decentralized compounds will be released to promote the application of blockchain technology in the health sector.May 25, 2025:
The company will further expand the scale of related experiments, continuing to deepen research on health, aging, and cellular health, exploring new scientific frontiers.
DeSci ecological tokens: $URO, $RIF, and $VITA
In the rapidly evolving field of decentralized science (DeSci), several representative tokens have gained widespread attention, particularly the following:
$URO (Urolithin A):
Urolithin A is a natural compound commonly found in tannin-rich foods, such as pomegranates. Research suggests that Urolithin A helps clear waste from cells, improves cell health, and may potentially slow down aging. Although $UROshowed a6.35% lifespan extension in the last round of experiments, but due to its relatively small market capitalization of about$63 million, its market performance has been relatively stable.$RIF (Rifampicin):
Rifampicin is an antibiotic with potential anti-aging and metabolic health improvement effects, making it one of the important compounds in Pump Science's research.$RIFhas increased by52.10%, with strong market attention and investor interest.$VITA (VitaDAO):
VitaDAO is a decentralized autonomous organization focused on anti-aging and longevity research.$VITAtokens have recently performed strongly, with a market capitalization reaching$158 million, and the price has increased by62.10%, occupying an important position in the DeSci ecosystem.